Curasight publishes information memorandum in connection with forthcoming rights issue finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
COPENHAGEN, Denmark, Feb. 13, 2024 /PRNewswire/ Curasight A/S Curasight or the Company – has today resolved on a new issue of shares with preferential rights for the Company s existing.
USD 500.000 payment is the first milestone under the global license and collaboration agreement for the development and commercialization of uTRACE® for use in.
Preclinical studies show uTREAT® effective in treating non-small cell lung cancer Data follows recent announcement of positive preclinical results within glioblastoma and supports hypothesis.